
Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc.(XENE)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
xene · 股价预测 · 22 位分析师(近3月)· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 22 位华尔街分析师
Buy
22 位分析师
共识
评级分布
12 个月目标价
High
$100
Consensus
$85.00
+66.3% upside
Low
$60.00
Median: $89.5 · Last Close: $51.11
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$85.00
66.3% upside
High Target
$100
95.7%
Low Target
$60
17.4%
Current Price
$51.11
as of today
Based on analyst price targets, the XENE stock price prediction for the next 12 months ranges from $60 to $100. The consensus XENE price forecast of $85.00 implies 66.3% upside from the current price of $51.11.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $50.08 | ↓ 2.01% |
1-day model range: $49.93–$50.23. Peak: $50.23 (-2.01%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · XENE · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-27 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-05-12 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-05-08 | Needham | Maintains | Buy→Buy |
| 2026-05-08 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-03-16 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-10 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-03-10 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-10 | Deutsche Bank | Maintains | Buy→Buy |
| 2026-03-09 | Baird | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Xenon Pharmaceuticals Inc. (XENE) stock. Of the recent 103 rating actions, 0 were upgrades and 0 were downgrades. 22 analysts currently cover XENE.
分析师推荐趋势
XENE analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 4 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$2M
↓ 99.3% YoY
Revenue Next Year
$57M
↑ 2661.9% YoY
EPS This Year
$-4.78
EPS Next Year
$-4.93
↑ 3.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast XENE EPS of $-4.78 for the current fiscal year, based on estimates from 14 analysts. The XENE revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
XENE 股价预测由两类独立数据源支撑:来自 22 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。XENE 的共识目标价为 $85.00(+66.3% 上行空间),分析师共识为 Buy。
XENE 的短期预测(明日)为 $50.08(-2.01%)。
Xenon Pharmaceuticals Inc. 在 NASDAQ 上市,代码 XENE。XENE 在 2027 年的整体展望偏积极,在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
XENE 预测 · 8 个问题根据 22 位华尔街分析师,XENE 的 12 个月平均目标价为 $85.00,最高 $100.00、最低 $60.00。若有图表,中位目标价可在上方查看。相对当前价 $51.11,隐含约 +66.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.